Pilotto, Andrea http://orcid.org/0000-0003-2029-6606
Cristillo, Viviana
Cotti Piccinelli, Stefano
Zoppi, Nicola
Bonzi, Giulio
Sattin, Davide
Schiavolin, Silvia
Raggi, Alberto
Canale, Antonio
Gipponi, Stefano
Libri, Ilenia
Frigerio, Martina
Bezzi, Michela
Leonardi, Matilde
Padovani, Alessandro
Funding for this research was provided by:
Università degli Studi di Brescia
Article History
Received: 2 May 2021
Accepted: 26 August 2021
First Online: 15 September 2021
Change Date: 17 March 2022
Change Type: Update
Change Details: The First name initial for first author is missing online citation. This has been corrected.
Declarations
:
: Andrea Pilotto served on the advisory board of Z-cube (technology division of Zambon pharmaceuticals); he received honoraria from Z-cube s.r.l., Biomarin, Zambon, Abbvie, Nutricia and Chiesi pharmaceuticals. He received research support from Vitaflo Germany and Zambon Italy.Viviana Cristillo has no financial conflicts to disclose.Stefano Cotti Piccinelli has no financial conflicts to disclose.Nicola Zoppi has no financial conflicts to disclose.Giulio Bonzi has no financial conflicts to disclose.Davide Sattin has no financial conflicts to disclose.Silvia Schiavolin has no financial conflicts to disclose.Alberto Raggi has no financial conflicts to disclose.Antonio Canale has no financial conflicts to disclose.Stefano Gipponi has no financial conflicts to disclose.Ilenia Libri has no financial conflicts to disclose.Martina Frigerio has no financial conflicts to disclose.Michela Bezzi has no financial conflicts to disclose.Matilde Leonardi has no financial conflicts to disclose.Alessandro Padovani is consultant and served on the scientific advisory board of GE Healthcare, Eli-Lilly and Actelion Ltd. Pharmaceuticals and received speaker honoraria from Nutricia, PIAM, Langstone Technology, GE Healthcare, Lilly, UCB Pharma and Chiesi Pharmaceuticals. He is funded by grant of the Ministry of University (MURST).
: The study was approved by the local ethics committee of ASST “Spedali Civili di Brescia” Hospital and the requirement for informed consent was waived by the Ethics Commission (NP 4166).